Anirag Bansal

Anirag Bansal

Active Director Whole-Time Director DIN 06499049
DIN 06499049 First appointment Feb 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Feb 2013
Shareholding value •••• Premium profile

About Anirag Bansal

Data last updated:

Anirag Bansal is a Whole-Time Director at Lucent Biotech Limited (since 2013), Director at Unnati Infracon Private Limited (since 2021) and Director at Advantage Constructions Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, Real Estate and Real Estate and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹70.24 Cr; the largest is Lucent Biotech Limited at ₹70.00 Cr (FY 2025). Earlier, Anirag Bansal was a Director at Pratha Constructions Private Limited (2021–2022).

DIN 06499049
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 15 Feb 2013
Oldest Company Age 21 yrs
Largest company Lucent Biotech Limited · ₹70.00 Cr (FY 2025)
Combined revenue ₹70.24 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lucent Biotech Limited U24232UP2005PLC029816
Whole-Time Director15 Feb 20132005₹70.00 Cr (FY 2025)Active
Unnati Infracon Private Limited U70102UP2011PTC047759
Director22 Mar 20212011₹18.2 Lakh (FY 2017)Active
Director22 Mar 20212008₹5.1 Lakh (FY 2017)Active
Raag Infrapromoters Private Limited U70102UP2012PTC053643
Director22 Mar 20212012₹99,938 (FY 2024)Active
Indven Pharma Private Limited U46497UP2024PTC212017
Director19 Nov 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pratha Constructions Private Limited U70102UP2012PTC053642
Director22 Mar 20212012Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Anirag Bansal

Directorship timeline

Open interactive timeline →
Lucent Biotech Limited
Advantage Constructions Private Limited
Unnati Infracon Private Limited
Raag Infrapromoters Private Limited
Premium access

Shareholding and investment profile for Anirag Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anirag Bansal

Anirag Bansal currently holds 5 directorships: Lucent Biotech Limited (Whole-Time Director, since 15 Feb 2013, revenue ₹70.00 Cr (FY 2025)); Unnati Infracon Private Limited (Director, since 22 Mar 2021, revenue ₹18.2 Lakh (FY 2017)); Advantage Constructions Private Limited (Director, since 22 Mar 2021, revenue ₹5.1 Lakh (FY 2017)); Raag Infrapromoters Private Limited (Director, since 22 Mar 2021, revenue ₹99,938 (FY 2024)); Indven Pharma Private Limited (Director, since 19 Nov 2024).

Anirag Bansal was first appointed on 15 Feb 2013 as Whole-Time Director at Lucent Biotech Limited. The most recent appointment on record is 19 Nov 2024 at Indven Pharma Private Limited.

The 4 current companies of Anirag Bansal that report revenue have a combined latest revenue of ₹70.24 Cr: Lucent Biotech Limited ₹70.00 Cr (FY 2025); Unnati Infracon Private Limited ₹18.2 Lakh (FY 2017); Advantage Constructions Private Limited ₹5.1 Lakh (FY 2017); Raag Infrapromoters Private Limited ₹99,938 (FY 2024).

Anirag Bansal held 1 earlier board appointment: Pratha Constructions Private Limited (Director, 22 Mar 2021 to 10 Jan 2022).

The current boards of Anirag Bansal's companies include Anil Kumar Agrawal (Lucent Biotech Limited), Anil Kumar Bansal (Lucent Biotech Limited), Anmol Bansal (Lucent Biotech Limited), Shivani Garg (Unnati Infracon Private Limited), Ragini Bansal (Indven Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available